miR-31 is distinctively overexpressed in primary male extramammary Paget's disease
Metrics: PDF 1090 views | HTML 1193 views | ?
Hao Guo1,*, Rui-Qun Qi1,*, Ya-Ni Lv1, He-Xiao Wang1, Yu-Xiao Hong1, Song Zheng1, Jiu-Hong Li1, Xing-Hua Gao1, Hong-Duo Chen1
1Department of Dermatology, No.1 Hospital of China Medical University, Shenyang, China
*These authors have contributed equally to this work
Hong-Duo Chen, e-mail: firstname.lastname@example.org
Xing-Hua Gao, e-mail: email@example.com
Jiu-Hong Li, e-mail: Pfkl2011@126.com
Keywords: miRNA, miR-31, non-melanoma skin cancer, extramammary Paget’s disease, apocrine glands
Received: December 12, 2015 Accepted: February 28, 2016 Published: March 21, 2016
MicroRNAs (miRNAs) are small noncoding RNAs involved in cancer development. Extramammary Paget’s disease (EMPD) is a rare cutaneous malignancy and the role of miRNAs in EMPD remains unknown. Here, we used TaqMan miRNA arrays to characterize miRNA expression profile in EMPD and further validated the candidates by single RT-PCR. Total 12 cases EMPD were involved in this study. Using laser capture micro-dissection technique, we collected EMPD tumor cells (ET, n=12), normal epidermal cells (NE, n=12) and normal apocrine glands cells (NA, n=7). MiRNA arrays from two pairs of ET and corresponding NE showed that miR-375, miR-10b, miR-31, miR-31* were differentially expressed. The single real-time PCR (RT-PCR) further confirmed that miR-375, miR-31 and miR-31* were upregulated in EMPD cells than those of the normal epidermis and apocrine glands. Our preliminary study suggested that these miRNAs could be involved in EMPD development and miR-31 may serve as potential biomarkers of EMPD.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.